Published in
Elsevier, Gastroenterology, 7(160), p. 2354-2366.e11, 2021
DOI: 10.1053/j.gastro.2021.02.062
Links
Tools
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease
Journal article published in 2021 by
Stefan Schreiber,
Konrad Aden 
,
Joana P. Bernardes,
Claudio Conrad,
Florian Tran,
Hanna Höper,
Valery Volk,
Neha Mishra,
Johanna Ira Blase,
Susanna Nikolaus,
Johannes Bethge,
Tanja Kühbacher,
Christoph Röcken,
Minhu Chen,
Ian Cottingham
and other authors.
,
Joana P. Bernardes,
Claudio Conrad,
Florian Tran,
Hanna Höper,
Valery Volk,
Neha Mishra,
Johanna Ira Blase,
Susanna Nikolaus,
Johannes Bethge,
Tanja Kühbacher,
Christoph Röcken,
Minhu Chen,
Ian Cottingham
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 